Literature DB >> 15765266

Frontal lobe dysfunction associated with glucose hypometabolism in aceruloplasminemia.

Hiroaki Miyajima, Yoshitomo Takahashi, Satoshi Kono, Akira Hishida, Kuniko Ishikawa, Masanobu Sakamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15765266     DOI： 10.1007/s00415-005-0796-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.

Authors:  A Feigin; K L Leenders; J R Moeller; J Missimer; G Kuenig; P Spetsieris; A Antonini; D Eidelberg
Journal:  J Nucl Med       Date:  2001-11       Impact factor: 10.057

2.  Frontal cortex and behavior.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1986-04       Impact factor: 10.422

3.  Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.

Authors:  T Kuwert; H Hefter; D Scholz; M Milz; P Weiss; G Arendt; H Herzog; M Loken; M Hennerici; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1992

4.  A modified card sorting test sensitive to frontal lobe defects.

Authors:  H E Nelson
Journal:  Cortex       Date:  1976-12       Impact factor: 4.027

5.  Glucose and oxygen hypometabolism in aceruloplasminemia brains.

Authors:  Hiroaki Miyajima; Yoshitomo Takahashi; Satoshi Kono; Masahiro Sugimoto; Yoji Suzuki; Akira Hishida; Masanobu Sakamoto; Yasuomi Ouchi
Journal:  Intern Med       Date:  2002-03       Impact factor: 1.271

6.  Aceruloplasminemia, an inherited disorder of iron metabolism.

Authors:  Hiroaki Miyajima; Yoshitomo Takahashi; Satoshi Kono
Journal:  Biometals       Date:  2003-03       Impact factor: 2.949

7.  Wilson's disease studied with FDG and positron emission tomography.

Authors:  R A Hawkins; J C Mazziotta; M E Phelps
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

8.  Clinical, molecular, and PET study of a case of aceruloplasminaemia presenting with focal cranial dyskinesia.

Authors:  I Haemers; S Kono; S Goldman; J D Gitlin; M Pandolfo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

9.  Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.

Authors:  D E Kuhl; M E Phelps; C H Markham; E J Metter; W H Riege; J Winter
Journal:  Ann Neurol       Date:  1982-11       Impact factor: 10.422
  9 in total
  2 in total

1.  The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.

Authors:  Bradleigh D Hayhow; Islam Hassan; Jeffrey C L Looi; Francesco Gaillard; Dennis Velakoulis; Mark Walterfang
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-08-26

2.  Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.

Authors:  Maki Watanabe; Ken Ohyama; Masashi Suzuki; Yasunobu Nosaki; Takashi Hara; Katsushige Iwai; Satoshi Kono; Hiroaki Miyajima; Kenji Mokuno
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.